Trial Site Detail
Drug: |
PLX3397 (PLX108-01) |
|||
|---|---|---|---|---|
Trial: |
Safety Study of PLX108-01 in Patients With Solid Tumors |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Vanderbilt-Ingram Cancer Center2220 Pierce Ave. 691 Preston Building |
Principal Investigator: |
Igor Puzanov, MD |
|---|---|
Contact: |
Wendy VerMeulen, RN 800-811-8480 wendy.vermeulen@vanderbilt.edu |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Vanderbilt-Ingram Cancer Center Website: |
http://www.vicc.org/ct/ |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.